Home / People / Pavel Dřimal
Image of Pavel Drimal

Pavel Dřimal

Associate

Contact
T +420 296 798 854
CMS Cameron McKenna Nabarro Olswang, advokáti, v.o.s.
Palladium, Na Poříčí 1079/3a
110 00 Prague 1
Czech Republic
Languages Czech, Slovak, English

Pavel is an Associate in the Corporate/M&A Team at CMS in Prague.

more less

Education

  • 2011 – Law Degree, Charles University, Prague 
more less

Memberships

  • Member of the Czech Bar Association
more less

Expertise

03/09/2014
CMS ad­vises on the sale of LBBW Bank Czech Re­pub­lic
CMS has ad­vised Landes­bank Baden-Württem­berg (LBBW) on the sale of its Czech sub­si­di­ary, LBBW Bank CZ a.s., to Ex­pobank from Rus­sia.LBBW Bank CZ is a mid-size uni­ver­sal bank with 18 branches in the Czech Re­pub­lic. The bank has op­er­ated in the mar­ket since 1991 and was ac­quired by LBBW in Septem­ber 2008. The parties have not an­nounced the pur­chase price.The trans­ac­tion was led by CMS Stut­tgart cor­por­ate part­ners Claus Peter Fa­bi­an and Thomas Meyding. The team from CMS Prague that ad­vised on the Czech as­pects was headed by cor­por­ate part­ner Helen Rod­well and in­cluded core mem­bers Pavla Krečková (Part­ner/Bank­ing & Fin­ance), Lukáš Janíček (Part­ner/Cor­por­ate), Mark Segall (Part­ner/In­ter­na­tion­al Bank­ing & Fin­ance), Pat­rik Przy­hoda (Seni­or As­so­ci­ate/Cor­por­ate), Miroslav Kovař (As­so­ci­ate/Bank­ing & Fin­ance) and Pavel Dřim­al (Ju­ni­or as­so­ci­ate/Cor­por­ate).
08/06/2015
CMS ad­vises Triglav in­sur­ance group on sale of Triglav pojišťovna, a.s.
CMS Prague has ad­vised the Slov­e­ni­an in­sur­ance com­pany Triglav INT, which is fully owned by Za­v­aroval­nica Triglav, on the sale of its Czech sub­si­di­ary Triglav pojišťovna, a.s. to VIGO Fin­ance, part of VIGO In­vest­ments Group.Triglav pojišt'ovna, is a non-life in­sur­ance com­pany in the Czech Re­pub­lic and was one of the nine in­sur­ance or re­in­sur­ance sub­si­di­ar­ies of the Triglav Group, one the largest in­sur­ance and fin­an­cial groups in South-East­ern Europe. Triglav reached an agree­ment with VIGO re­gard­ing the sale of its Czech sub­si­di­ary in Oc­to­ber last year. The sale was ap­proved by the Czech Na­tion­al Bank in May and reached clos­ing on 4 June.The CMS team ad­vising Triglav was led by cor­por­ate part­ner Pat­rik Przy­hoda and fur­ther com­prised seni­or as­so­ci­ate Radim Kot­laba and ju­ni­or as­so­ci­ate Pavel Drim­al.The trans­ac­tion re­af­firms CMS’ lead­ing po­s­i­tion in cor­por­ate trans­ac­tions in the fin­an­cial ser­vices sec­tor. In the last 12 months CMS Prague ad­vised on the sale of LBBW Czech Re­pub­lic to Ex­pobank as well as on the sale of mBank’s factor­ing com­pany Transfin­ance to Uni­Cred­it.

Feed

Show only
08/06/2015
CMS ad­vises Triglav in­sur­ance group on sale of Triglav pojišťovna, a.s.
CMS Prague has ad­vised the Slov­e­ni­an in­sur­ance com­pany Triglav INT, which is fully owned by Za­v­aroval­nica Triglav, on the sale of its Czech sub­si­di­ary Triglav pojišťovna, a.s. to VIGO Fin­ance, part of VIGO In­vest­ments Group.
20 April 2020
CMS Ex­pert Guide to ad­vert­ising of medi­cines and med­ic­al devices
Are you look­ing for in­form­a­tion on phar­ma­ceut­ic­al ad­vert­ising reg­u­la­tion and med­ic­al device ad­vert­ising? Learn more about it in this CMS Ex­pert Guide.
06 April 2020
Czech drug au­thor­ity re­com­mend­a­tions on clin­ic­al tri­als
The Czech State In­sti­tute for Drug Con­trol (SUKL) re­cently pub­lished its opin­ion on on­go­ing clin­ic­al tri­als and clin­ic­al tri­als that have not yet star­ted in light of the COV­ID-19 situ­ation. With the ex­cep­tion...
20 April 2020
CMS Ex­pert Guide to can­nabis law and le­gis­la­tion
Are you look­ing for in­form­a­tion on can­nabis law and le­gis­la­tion? This CMS Ex­pert Guide provides you with everything you need to know.
08 October 2019
Czech lower house de­fies Sen­ate and re­af­firms sup­port for Amend­ment to...
On 24 Septem­ber 2019, the lower house of the Czech par­lia­ment con­duc­ted a second vote on a draft Amend­ment to the Phar­ma­ceut­ic­als Act (No. 378/2007 Coll.), which was re­turned to the cham­ber after a vote...
02 August 2019
The Czech Re­pub­lic: Amend­ment to the Phar­ma­ceut­ic­als Act
On 25 Ju­ly 2019 the Czech Sen­ate dis­cussed a draft amend­ment to Act No. 378/2007 Coll., Phar­ma­ceut­ic­als Act, as amended (the “Amend­ment”) which was passed by the Cham­ber of Depu­ties at the end of...